Bladder Cancer News
June 13, 2025
Top Headlines
Apr. 11, 2025 — A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a new study. The method, based ...
Feb. 20, 2025 — Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts. The study has significant relevance, impacting the management of bladder cancer patients. ...
Feb. 5, 2025 — New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial infections globally, with more than 400 million cases reported ...
Jan. 14, 2025 — Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in ...
Dec. 3, 2024 — Researchers have identified a subset of brain cells in mice that act as the master regulators of ...
Nov. 13, 2024 — Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new ...
Nov. 12, 2024 — A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate ...
Oct. 9, 2024 — How bladder cancer originates and progresses has been illuminated as never before. Researchers found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development, and that standard ...
Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased risk include bladder, brain and cervical cancers. The study does not ...
Oct. 2, 2024 — Researchers have developed technology that can alter, within the body, the recognized identity of proteins, which allowed researchers to target mouse tumors with a protein and then transport that protein out of the body. This means that ...
May 21, 2024 — A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to new ...
Jan. 9, 2024 — More than 65,000 men fall ill with prostate cancer each year in Germany. Twelve thousand of them develop a treatment-resistant form which eventually ends in death. Now, a team of researchers has developed an active substance that might in future ...
Latest Headlines
updated 11:33am EDT
Jan. 15, 2025 — Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI ...
Sep. 19, 2024 — Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients ...
June 6, 2024 — In an advance that could improve bladder cancer treatment, a novel combination of cretostimogene grenadenorepvec and pembrolizumab has shown ...
Mar. 27, 2024 — Researchers say they have discovered that the protein puromycin-sensitive aminopeptidase (NPEPPS) plays a role in regulating response to platinum ...
Mar. 18, 2024 — Researchers have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC). The ...
Nov. 16, 2023 — For 40 years, chemotherapy has been the standard treatment for bladder cancer patients who can tolerate this medicine. However, the results were limited, and lasting results were rare. In recent ...
Oct. 25, 2023 — A high expression of the enzyme beta1,4-galactosyltransferase-3, or B4GALT3 is associated with noticeably shortened survival rates in several types of immunotherapy cancersdeficiency in mice TIME ...
Oct. 9, 2023 — Cancers that have a deletion in the 9p21 section of their genomes tend to have worse outcomes for patients and increased resistance to immunotherapy. A new, bio-inspired drug restores the ...
Oct. 2, 2023 — Investigators have developed a new approach for treating invasive bladder cancer without the need for surgical removal of the bladder. Removing the ...
July 12, 2023 — Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -- cisplatin. Now, researchers have developed the first therapy ...
Earlier Headlines
June 27, 2023 — A cancerous tumor is the accumulation of cells uncontrollably dividing, some of which can invade other parts of the body. The process is difficult to predict in detail, and eradicating the cells ...
June 21, 2023 — As men age, some of their cells lose the very thing that makes them biological males -- the Y chromosome -- and this loss hampers the body's ability to fight cancer, according to new research. ...
Mar. 15, 2023 — A new study represents a first step towards generating highly detailed 3-dimensional maps of lung tumors using genetically engineered mouse ...
Dec. 28, 2022 — An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a new study. The finding ...
Dec. 1, 2022 — About 80% of people with cancer suffer from significant muscle wasting, or loss of muscle tissue, and 30% of these patients die from this condition. New research in mice finds that the severity of ...
Oct. 5, 2022 — An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new study in mice. The ...
Sep. 12, 2022 — Researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research could lead to a new therapeutic option for patients ...
Aug. 22, 2022 — Many bladder cancer patients cannot tolerate the strong side effects of the gold standard treatment. Researchers have found a way to minimize those side effects and are poised to move into clinical ...
Aug. 4, 2022 — Investigators have identified genetic signatures that could predict whether tumors in patients with bladder and other cancers will respond to ...
July 12, 2022 — Development of a precision medicine technology based on artificial intelligence that predicts immunotherapy response in cancer ...